I have been collecting case studies of people with gall bladder and bile duct cancers.  Several have passed away, but their loved ones have expressed interest in sharing their experiences.  Send me an email and ask any questions you have, and I will forward it to them.

Woodyb@cox.net

2

(0 replies, posted in Chemotherapy)

I am on a regime of Gemzar and Taxotare which has been very hard on both me and my tumors.  Anyone else with this combination?

My first cycle was in October 2005, after which I had a major drop in blood counts, bleeding ulcers, 9 days in the hospital, and significant reduction in tumors and dropping CA19-9 levels which lasted for 8 months.  After a couple of short-lived clinical trials, I started my second cycle of Gemzar and Taxotare on November 2, 2006.  This time my oncologist followed up with daily blood tests which showed an 80% drop in WBC and platelets, causing the second infusion to be cancelled.  Although blood levels are back to normal, I have not had any more chemo, waiting for deteriorating results, but both the December and January scans and CA19-9 are improving.

Woody B

Jerry and Jeff - I make 3 with infusion problems.  At the end of a clinical trial, my porta-cath wasn't properly flushd, and 4 months later, after the nurses had difficulty clearing my porta-cath, they forced saline through which ruptured the catheter (which no one realized at the time).  I got some pre-meds and then the oxalyplatin was started.  After a while I complained about a sore chest and they realized that I was being infused into my chest through the ruptured porta-cath.  They stopped, and sent me home.  The good news is that I didn't have any of the cold sensitivity until after my next infusion.

I have been collecting case studies for gall bladder and bile duct cancer.  For a copy, send me an email at woodyb@cox.net.  If you cannot open Excel spreadsheets, let me know and I can send you a pdf document.

Woody B

Alison-
For the phase 3 XL119 study, you had to be treatment free for 6 months, plus additional criteria.  The study is detailed at
http://www.clinicaltrials.gov/ct/show/N … 25?order=1
If they are opening the XL119 to all participants (as I was told), they may also change the eligibiity requirements.
I will post any information I learn.

I am trying to develop a comprehensive data base of treatments and individual responses.  If you are willing to share your experiences, please email me at
woodyb  @   cox.net
and I will forward the suvey form and send you periodic updates of everything I learn.
Woody Beckman

5

(11 replies, posted in Clinical Trials)

I was in the XL119 phase 3 clinical study and dropped out because I was assigned to the control group rather than the XL119.
However, I just learned that the study is being changed to open status, and that all participants will get XL119.
This sounds like very good news.
Woody

I was in the XL119 phase 3 clinical study and dropped out because I was assigned to the control group rather than the XL119.
However, I just learned that the study is being changed to open status, and that all participants will get XL119.
This sounds like very good news.
Woody